Evaluating Effectiveness of Deferasirox Versus Deferoxamine in Improving Clinical Outcomes among Patients with Transfusion-Dependent Thalassemia: A Randomized Controlled Trial

Background: Transfusion-dependent β-thalassemia necessitates lifelong blood transfusions that progressively accumulate systemic iron, causing cardiomyopathy, hepatic cirrhosis, and endocrine failure without effective chelation. Deferasirox, a once-daily oral iron chelator, offers a pharmacological...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Muhammad Mohsin Shoukat, Hafiza Khadija Tariq, Fareed Ullah, Muhammad Arslan Liaqat, Areeba Sajjad, Nauman Akhtar
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Link Medical Interface 2025-12-01
Serie:	Link Medical Journal of Health and Community Research
Soggetti:	Adherence; Deferasirox; Deferoxamine; Iron Overload; Randomized Controlled Trial; Thalassemia; Transfusion-Dependent
Accesso online:	https://linkmjhcr.com/index.php/lmj/article/view/105
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!